
Kedrion Biopharma to be Honored for QIVIGY Innovation
Premier, Inc. has selected Kedrion Biopharma as an honoree for its upcoming 2026 Supplier Innovation Celebration. The award recognizes the company’s development of QIVIGY, an intravenous immunoglobulin therapy for adults with primary humoral immunodeficiency, which was approved by the U.S. Food and Drug Administration last year.

























